Armistice Capital, LLC Insulet Corp Transaction History

Armistice Capital, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$127.77 - $221.42 $207,498 - $359,586	1,624 New	1,624 $352,000
Q2 2023 Aug 14, 2023	BUY	$272.48 - $330.23 $1.09 Million - $1.32 Million	4,000 Added 16.67%	28,000 $8.07 Million
Q1 2023 May 15, 2023	SELL	$276.36 - $326.03 $3.04 Million - $3.59 Million	-11,000 Reduced 31.43%	24,000 $7.66 Million
Q4 2022 Feb 14, 2023	SELL	$212.22 - $313.46 $212,220 - $313,460	-1,000 Reduced 2.78%	35,000 $10.3 Million
Q3 2022 Nov 14, 2022	BUY	$224.6 - $281.45 $8.09 Million - $10.1 Million	36,000 New	36,000 $8.26 Million

685

62.7M

640K

881K

Ticker PODD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 69,403,600
Market Cap $18.1B
Description
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...

Get notified when there are updates to the investment portfolio of Armistice Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Armistice Capital, LLC with notifications on news.